This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Surgery in lung cancer

Authoring team

In general only 20% of all new cases of non-small cell lung cancer ever go to surgery. The overall 5-year survival after surgery is about 25%.

Absolute contraindications for surgery include:

  • patient refusal
  • metastases (CT scanning now detects metastases more frequently than a decade ago)

Relative contraindications include:

  • the cell type - small cell carcinoma are usually inoperable
  • poor respiratory reserve:
    • FEV1 > 1.2l is necessary for lobectomy, and > 1.8l for pneumonectomy
    • a raised PaCO2 is a contraindication for surgery
  • other disease - especially myocardial
  • mediastinal involvement
  • age - in patients over 70, surgery is usually inadvisable because the benefits are outweighed by operative morbidity and mortality

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.